Claude Science Launched

Caveman save you token, save you money, might define simple AI efficiency, but Anthropic is launching a far more sophisticated system for complex research. At an industry event yesterday, the company unveiled Claude Science, a major new flagship product designed to automate computational biology and drug discovery.

Much like their existing Claude Code tool assists software engineers, this new model can autonomously execute complex tasks from concise, high-level instructions. The release signals that Anthropic is significantly doubling down on scientific AI, even planning to use the system for its own research into treatments for rare and neglected diseases.

This development comes as the United States government reportedly lifted restrictions on Anthropic's Mythos and Fable models. While industry analysts note that many AI drug discovery claims remain unproven, Anthropic's new tool represents a major step toward moving these experimental technologies from promise to practice.